To The Moon

BIG BANKS KICK OFF Q1 EARNINGS: BEAT AND FADE, OR IS THE RALLY JUST STARTING? The Q1 2026 earnings season is officially opening its doors, and the spotlight is glaring directly on Wall Street's heavyweights. Expectations are sky-high for giants like Citi, Wells Fargo, and Morgan Stanley, driven by a resurgence in deal-making, robust trading revenues, and resilient Net Interest Income (NII). But with the financials sector already heavily bid up heading into these prints, a massive tension is building on the tape: if the numbers are merely "good," will the market ruthlessly fade the news? Here is why this bank earnings kickoff is a massive psychological trap, and what the smart money is actually watching behind the headline numbers.  1️⃣ The "Priced for Perfection" Trap Retail traders o

$Oracle(ORCL)$  Bleeds to $137: Is This a Value Trap or the Ultimate Tech Dip Buy? Oracle (ORCL) just took another hit, shedding 3.7% to close near $137.86. Right now, we are witnessing a brutal capital rotation out of steady, low-elasticity cloud players and straight into high-beta growth names like AMZN, cybersecurity, and the broader semiconductor sector. Even Oracle’s shiny new AI-driven fusion agent applications failed to move the needle, met with complete apathy by the market. The big question for traders now: is Oracle genuinely oversold, or just catching up to a broader software valuation reset? Here is the breakdown of what is actually happening under the hood, and how to play the setup. 1️⃣ The Great Capital Rotation: Why ORCL is Bl

$Amazon.com(AMZN)$  AMZN Surges 6%: AWS Awakens, But Is $240 the Ultimate Profit-Taking Zone? Amazon (AMZN) just posted a massive 5.60% green candle, ripping to $233.65 and cementing itself as one of the top three S&P 500 gainers on the day. This isn't just a random retail pump; this is heavy institutional money rotating aggressively back into the e-commerce and cloud giant. The catalyst? Tangible proof that AWS is finally monetizing its AI agent services, shaking off the lingering fears that Microsoft’s Azure had permanently stolen the AI cloud crown. With the stock rapidly approaching near-term resistance, the market is completely divided. Here is a look under the hood at what is driving this breakout and how traders should be playing t

Intel’s 16% Rip: Is the $70 Breakout Inevitable or Just a Momentum Trap? Intel (INTC) is suddenly trading like a hyper-growth tech darling. The stock surged another 4.70% to close near $61.72, capping off a blistering three-day run that added over 16% to its valuation. The main fuel for this fire? Exploding narrative traction around its Terafab AI compute project and a massive institutional rotation into domestic AI supply chains. With the massive psychological ceiling of $60 flipping into confirmed intraday support, Wall Street’s $70 price targets are suddenly in sharp focus. But with no tangible revenue from Terafab yet, traders need to ask: is this a structural turnaround, or are we just pricing in a dream? Here is how to read the tape. 1️⃣ The "Domestic AI Premium" Narrative Institutio

TSLA & MSFT Miss the Market Rip: Pre-Earnings De-Risking or the Ultimate Dip Buy? ​The broader market is catching a serious bid right now, but two of the heaviest hitters in the index—Tesla (TSLA) and Microsoft (MSFT)—are completely sitting out the dance. Tesla is still nursing its wounds after a weak Q1 delivery print, while Microsoft is experiencing a rare momentum pause as Wall Street holds its breath ahead of upcoming earnings. With Tesla’s critical Q1 report dropping on April 22 and Microsoft’s right around the corner, this stark divergence from the broader rally is the most important setup on the board. ​Are big funds just clearing the deck and de-risking before earnings, or is this the exact moment contrarians should be stepping in? Let’s break down the tape. ​1️⃣ Tesla’s Q1 Rea

$Goldman Sachs(GS)$ $JPMorgan Chase(JPM)$  $Charles Schwab(SCHW)$  📊🇺🇸 📈 Q1 2026 Earnings Volatility Roadmap: Bank Implied Moves, Fee Rotation Dynamics and Macro Triangulation for 13Apr26 Week 📈🇺🇸📊 💡 Options Market Positioning: Precision Risk Pricing Across the Financial Complex Implied earnings moves for the major banks remain tightly clustered in the 3.4%–4.7% range, signalling disciplined uncertainty rather than systemic stress: $GS ±4.1% $JPM ±3.4% $BLK ±4.0% $C ±4.0% $WFC ±4.1% $BAC ±3.8% $MS ±4.2% $PNC ±3.7% $SCHW ±4.7% $USB ±3.9% $FITB ±4.3% $ALLY ±4.4% This band reflects a market pricing revenue-mix evolution with precision, specifically

Firstly The price action was already showing resiliency last Thursday before the Good Friday holiday. The market went down initially following Trump’s national address over the Iran war update, as investors were anticipating an end to the war—but Trump said to continue instead. Yet the market recovered almost all its losses by end of day, showing strength. Some investors may still think that the worst isn’t over because the ceasefire looks fragile—Israel is bombarding Lebanon and Iran said the ceasefire includes non-bombing of Lebanon. Iran has continued to restrict ship passage through the Strait of Hormuz to about a dozen a day and is imposing tolls. The US isn’t happy about the tolls as the ceasefire was contingent on an open Hormuz. The following Tuesday was the deadline for Iran to op

Definitely follow the smart money. Keppel DC reit would do well in the future. AI and tech is here to stay and the demand would be exponential into the future yet land remains scarce in Singapore. Demand for data centres would definitely grow which works well for Keppel dc reit. Capland Ascendas reit has always been a hot favourite among retail investors. Nothing wrong with it. Fundamentals remain strong and it should remain as a strong stock with good capital returns and dividends returns for the near future but i still see Keppel dc reit as a stronger stock and more worthy of my investment as I do foresee it outshining capland Ascendas reit for both growth and dividend returns. I would be looking to add more Keppel dc reit. Alternatively, for many of us, I just buy the ETF! That is so mu

You are framing the right tension. In this setup, the “beat” matters far less than the forward signal. 1) What actually drives price now For large banks like Citigroup, Wells Fargo, and Morgan Stanley: Q1 numbers = backward-looking Trading + deal fees tend to be cyclical and already visible via market activity Net interest income (NII) is largely modelled ahead of time Guidance = repricing catalyst 2026 NII trajectory (rate cuts vs stickiness) Investment banking pipeline (is deal momentum durable?) Credit quality (early stress signals matter more than beats) 👉 In this environment, guidance > beat, unless the beat is materially outside expectations. --- 2) Market positioning matters more than the print Right now the market is: Already expecting “solid” quarters Positioned for stabilising

The information and materials provided here, whether or not provided on TBI’s Substack (TBI), on third party websites, in marketing materials, newsletters or any form of publication are provided for general information and circulation only. None of the information contained here constitutes an offer (or solicitation of an offer) to buy or sell any currency, product or financial instrument, to make any investment, or to participate in any particular trading strategy. TBI does not take into account of your personal investment objectives, specific investment goals, specific needs or financial situation and makes no representation and assumes no liability to the accuracy or completeness of the information provided here. The information and publications are not intended to be and do not constit

Who’s winning the oral weight-loss drug race? The GLP-1 weight-loss market is shifting from injectables to oral pills — and it’s still Novo vs. Lilly at the top. Which giant has stronger long-term momentum? Let’s break it down clearly. The weight-loss drug race is moving from the injectable first half to the oral second half. Late last year, the first oral GLP-1 weight-loss drug was approved, and analysts project the market will near $100 billion by 2030. At the table are the same two giants: Denmark’s Novo Nordisk (NVO) and U.S. star Eli Lilly (LLY). In the injectable era, Lilly overtook the market with superior efficacy from tirzepatide (Mounjaro/Zepbound) and aggressive production expansion, capturing 60% of the U.S. market. Now the battlefield has shifted to oral drugs. Can Novo Nordis

Most people still think of SanDisk as the little USB drive in their desk drawer. The market has a very different view now. SNDK soared 9.05% to $851.57 on April 10, touching an intraday high of $855 to set a fresh all-time record. That extends one of the most extraordinary runs in semiconductor history. From a post-spinoff panic low of $27.89 on April 7, 2025, the stock has returned 30x in exactly twelve months. A $10,000 position at last year's low is worth $305,500 today. MU followed, climbing 3.63% to $421.51 for a third consecutive session with a cumulative 14% gain. The storage bull run is accelerating. Here is everything behind it, and the critical question: how much further can it go? 🏭 The New SanDisk You Need to Understand This is not the thumb drive company anymore. SanDisk separ

The AI Inference boom is now driving demand across the full compute stack from silicon & memory to optics, power, packaging & cloud: • AI Silicon: $NVIDIA(NVDA)$, $Advanced Micro Devices(AMD)$, $Broadcom(AVGO)$, $Intel(INTC)$ • Foundry & Packaging: $Taiwan Semiconductor Manufacturing(TSM)$, $Amkor Technology(AMKR)$, $GLOBALFOUNDRIES Inc.(GFS)$ • Memory & Storage:

Current Market Position: Gold prices are stuck in a "can't fall, can't rise" pattern within the $4700-$4800 range. On the daily chart, the MACD histogram continues to expand, indicating strong bullish momentum. However, the KDJ indicator's J value has entered a strong zone and is approaching overbought territory, suggesting a short-term need for consolidation. The 4-hour chart shows short-term moving averages turning downwards, with the price trading below the MA5/MA10. The MACD has turned from red to green, and the green histogram is gradually increasing in volume, indicating emerging bearish momentum. Key Price Levels for Bulls and Bears$Gold - main 2606(GCmain)$ Level | Direction | Price (USD/oz) | Explanation: Premium Resis

Hello everyone! Today i want to share some trading ideas with you! 1 From early February into the end of March, we watched $S&P 500(.SPX)$ drop nearly 700 points. Every week felt worse than the last. Retail kept trying to buy every dip and got chopped up. By the time we bottomed, sentiment was at max fear. No confidence, no hope. And we bottomed around the same time as 2025… in April. Now flip it. When $S&P 500(.SPX)$ reclaims 7000, you’re going to see the same emotion… just in the opposite direction. Doubt, fear mongering, people calling tops the entire way up into 7700–8000. Traders will try to short when they should be going long. And most will miss the move. Whe